Ence Chuck 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Ence Chuck
CAO and COO
Transactions
- Other
Stock Option (right to buy)
2022-12-16−200,000→ 0 totalExercise: $19.03Exp: 2031-12-17→ Common stock (200,000 underlying)
Footnotes (3)
- [F1]Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated.
- [F2]Not applicable.
- [F3]Original expiration date.